First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

BACKGROUND: To compare the efficacy of first‐line bevacizumab plus chemotherapy with cetuximab plus chemotherapy based on the stratification of metastatic colorectal cancer (mCRC) patients with mucinous adenocarcinoma (MA) or mucinous component (MC). METHODS: A retrospective study involving all mCRC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Zhou, Yu‐Wen, Long, Yi‐Xiu, Chen, Ye, Liu, Ji‐Yan, Pu, Dan, Huang, Jia‐Yan, Bi, Feng, Li, Qiu, Gou, Hong‐Feng, Qiu, Meng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Cancer Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8124114/
https://ncbi.nlm.nih.gov/pubmed/33939281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados